Concepedia

Joshua J. McFarlane

JJ

7

Publications

419

Citations

7

H-Index

2008

Active since

Affiliations

Virginia Cancer Institute(Current)

Tennessee Oncology

Sarah Cannon

Comprehensive Cancer Centers of Nevada

Nebraska Cancer Specialists

Joshua J. McFarlane is an author at Virginia Cancer Institute specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

2008–2020

7

Publications

7

Secondary Colorectal Carcinoma After Childhood Cancer

Kerri Nottage, Joshua J. McFarlane, Matthew J. Krasin et al. · Journal of Clinical Oncology · 2012 · 116 citations · Full text

Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study

Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane et al. · Clinical Genitourinary Cancer · 2020 · 101 citations · Full text

A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer

Johanna C. Bendell, Howard S. Höchster, Lowell L. Hart et al. · The Oncologist · 2017 · 59 citations · Full text

Causes and Consequences of Deviation from Multidisciplinary Care in Thoracic Oncology

Raymond U. Osarogiagbon, Gregory L Phelps, Joshua J. McFarlane et al. · Journal of Thoracic Oncology · 2011 · 51 citations · Full text

, , +7

SPIKE$: A Six-Step Protocol for Delivering Bad News About the Cost of Medical Care

Joshua J. McFarlane, Jerry Riggins, Thomas J. Smith · Journal of Clinical Oncology · 2008 · 44 citations

, , +20

Rows per page

1–5 of 7